Comparing two brain targets for non-invasive stimulation in Parkinson's
Part of Brain & nervous system clinical trials.
This study compares two areas of the brain (subthalamic nucleus and globus pallidus interna) for stimulation using a new non-invasive technique called tTIS. The goal is to see which area works better to improve Parkinson's symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of Parkinson's disease.
- Your Parkinson's is at a mild to moderate stage (Hoehn & Yahr stage 3 or less).
- Your Parkinson's medications have been the same for the past four weeks and will stay the same during the trial.
- You do not have other brain conditions like a past head injury.
- You are not taking certain psychiatric medications (antipsychotics, antidepressants, or drugs that affect dopamine, besides Parkinson's drugs).
- You have no metal implants in your head or chest (like a deep brain stimulator or pacemaker).
- Your vital signs (e.g., blood pressure) are stable.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new type of brain stimulation (STN-tTIS) to see if it helps improve movement symptoms in people with Parkinson's. The study compares how the stimulation works when you are taking your regular medications and when you are not.
This trial tests a precise form of brain stimulation (called TMS) to see if it can improve movement problems like stiffness, slowness, or tremors in people with Parkinson's disease. Participants must have a stable medication routine and no metal implants or brain surgery history.
This trial tests a non-invasive brain stimulation technique called transcranial direct current stimulation (tDCS) to see if it can improve motor function in people with Parkinson's disease. The treatment uses mild electrical currents applied to the scalp to stimulate brain areas involved in movement.
This trial tests a new type of brain stimulation (called temporal interference stimulation) targeted at specific brain regions to help improve Parkinson's disease symptoms. Researchers will use MRI imaging and behavioral assessments to see if this approach can reduce movement problems and improve quality of life.
This study looks at how the brain “filters” sensory information in people with advanced Parkinson’s disease, using brain imaging and deep brain stimulation (DBS) that you may already be getting as routine care. The goal is to better understand what drives Parkinson’s symptoms and how DBS might affect the brain.
This study compares different schedules of a non-invasive brain stimulation treatment (called tTIS) to standard medication for Parkinson's disease. It aims to find the best timing for tTIS to improve motor symptoms.
Hear when a new Parkinson Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.